Review



ckd progression  (Selleck Chemicals)


Bioz Verified Symbol Selleck Chemicals is a verified supplier
Bioz Manufacturer Symbol Selleck Chemicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Selleck Chemicals ckd progression
    Ckd Progression, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 226 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ckd+progression/Tofacitinib/10__1096_slash_fj__202402318r-33-10-16
    Average 96 stars, based on 226 article reviews
    ckd progression - by Bioz Stars, 2026-09
    96/100 stars

    Images

    Related Articles

    other:

    Article Title: CD11b deficiency attenuates the ischemia/reperfusion‐induced AKI‐to‐CKD process by regulating macrophage polarization
    Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Number: 82470761, 82370685 and 82102146; Shanghai Clinical Research Center for Kidney Disease, Grant/Award Number: 22MC1940100; Shanghai Key Laboratory of Kidney and Blood Purification, Grant/Award Number: 20DZ2271600; Shanghai Medical Centre of Kidney, Grant/Award Number: 2017ZZ01015; Shanghai Municipal Key Clinical Specialty, Grant/Award Number: shslczdzk02501; Shanghai Federation of Nephrology Project supported by Shanghai ShenKang Hospital Development Center, Grant/ Award Number: SHDC2202230 Abstract Severe acute kidney injury (AKI) is a risk factor for the future development of chronic kidney disease (CKD), and macrophages are an essential cell group implicated in injury, repair, and fibrosis during this progress.. However, the underlying mechanism of how macrophages participate in the development of the disease is largely unclear.. CD11b (Integrin αM) is highly expressed in monocytes/ macrophages and has been verified to mediate broad functions.



    Similar Products

    96
    Selleck Chemicals ckd progression
    Ckd Progression, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ckd+progression/Tofacitinib/10__1096_slash_fj__202402318r-33-10-16
    Average 96 stars, based on 1 article reviews
    ckd progression - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    90
    MyBiosource Biotechnology ckd – progression
    Sample type, FGF-23 assay kit and study objectives for the 17 articles included in the scoping review
    Ckd – Progression, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ckd+progression/ckd+++progression/pmc11103316-75-7-5
    Average 90 stars, based on 1 article reviews
    ckd – progression - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Wolters Kluwer Health controlled trial of slowing of kidney disease progression from the inhibition of xanthine oxidase (ckd-fix)
    Sample type, FGF-23 assay kit and study objectives for the 17 articles included in the scoping review
    Controlled Trial Of Slowing Of Kidney Disease Progression From The Inhibition Of Xanthine Oxidase (Ckd Fix), supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ckd+progression/controlled+trial+of+slowing+of+kidney+disease+progression+from+the+inhibition+of+xanthine+oxidase++ckd+fix+/10__1097_slash_fjc__0000000000001482-148-12-21
    Average 90 stars, based on 1 article reviews
    controlled trial of slowing of kidney disease progression from the inhibition of xanthine oxidase (ckd-fix) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Credence Genomics composite ckd progression score index
    Sample type, FGF-23 assay kit and study objectives for the 17 articles included in the scoping review
    Composite Ckd Progression Score Index, supplied by Credence Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ckd+progression/composite+ckd+progression+score+index/pm36881606-71-8-7
    Average 90 stars, based on 1 article reviews
    composite ckd progression score index - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    99
    STATA Corporation ckd progression stata
    Sample type, FGF-23 assay kit and study objectives for the 17 articles included in the scoping review
    Ckd Progression Stata, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ckd+progression/STATA+14%2E0/pm32034854-58-4-6
    Average 99 stars, based on 1 article reviews
    ckd progression stata - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    STATA Corporation ckd progression
    Sample type, FGF-23 assay kit and study objectives for the 17 articles included in the scoping review
    Ckd Progression, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ckd+progression/STATA+14%2E0/pmc06050937-252-3-8
    Average 99 stars, based on 1 article reviews
    ckd progression - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    Image Search Results


    Sample type, FGF-23 assay kit and study objectives for the 17 articles included in the scoping review

    Journal: Journal of Feline Medicine and Surgery

    Article Title: Blood fibroblast growth factor 23 concentration in cats with and without chronic kidney disease: a scoping review

    doi: 10.1177/1098612X241234984

    Figure Lengend Snippet: Sample type, FGF-23 assay kit and study objectives for the 17 articles included in the scoping review

    Article Snippet: Liao et al, 2019 , MyBioSource , CKD – progression , 33 , 11 (8–15) , 245.0 , 201.5 , 491.5.

    Techniques: Clinical Proteomics, Biomarker Discovery, Concentration Assay

    Study type, country and time frame for sample collection, definition of  CKD  and inclusion/exclusion criteria for the studies of fibroblast growth factor 23 in cats

    Journal: Journal of Feline Medicine and Surgery

    Article Title: Blood fibroblast growth factor 23 concentration in cats with and without chronic kidney disease: a scoping review

    doi: 10.1177/1098612X241234984

    Figure Lengend Snippet: Study type, country and time frame for sample collection, definition of CKD and inclusion/exclusion criteria for the studies of fibroblast growth factor 23 in cats

    Article Snippet: Liao et al, 2019 , MyBioSource , CKD – progression , 33 , 11 (8–15) , 245.0 , 201.5 , 491.5.

    Techniques: Clinical Proteomics, Medications, Concentration Assay, Biomarker Discovery, Imaging

    Article characteristics and population information for studies evaluating serum or plasma concentrations of fibroblast growth factor-23 (pg/mL) in healthy cats and in cats with  CKD  stages 1–4

    Journal: Journal of Feline Medicine and Surgery

    Article Title: Blood fibroblast growth factor 23 concentration in cats with and without chronic kidney disease: a scoping review

    doi: 10.1177/1098612X241234984

    Figure Lengend Snippet: Article characteristics and population information for studies evaluating serum or plasma concentrations of fibroblast growth factor-23 (pg/mL) in healthy cats and in cats with CKD stages 1–4

    Article Snippet: Liao et al, 2019 , MyBioSource , CKD – progression , 33 , 11 (8–15) , 245.0 , 201.5 , 491.5.

    Techniques: Clinical Proteomics

    Article characteristics and population information for studies evaluating serum or plasma concentrations of FGF-23 (pg/ml) in cats with progressive or non-progressive  CKD

    Journal: Journal of Feline Medicine and Surgery

    Article Title: Blood fibroblast growth factor 23 concentration in cats with and without chronic kidney disease: a scoping review

    doi: 10.1177/1098612X241234984

    Figure Lengend Snippet: Article characteristics and population information for studies evaluating serum or plasma concentrations of FGF-23 (pg/ml) in cats with progressive or non-progressive CKD

    Article Snippet: Liao et al, 2019 , MyBioSource , CKD – progression , 33 , 11 (8–15) , 245.0 , 201.5 , 491.5.

    Techniques: Clinical Proteomics